Home > PORTAL > about Us > Presentation >
Discover the services provided by SPIN’s website
How does www.spindermatology.org work?
The SPIN website offers you several services:
>> World Directory of Psoriasis Medial Resources
An interactive map listing dermatology centres specialised in the management of psoriasis. For each centre listed in this directory, you can see which medical resources they provide to psoriasis patients: available treatments, dedicated inpatient/outpatient facilities, interdisciplinary consultations, clinical trials, collaboration with patient associations.
For each centre, you can learn how to get an appointment, and you have access to the postal address and contact information.
>> World Directory of Atopic Dermatitis Medial Resources (coming soon!)
>> PIN News
Each member of the network can contribute with articles, events, works, etc., as long as the documents are provided in English. In this section, you will find:
- Our "Focus On" on major works or events of the network or special showcases of our partner medical groups or patient associations; also, you will find the latest news published in our website
- The news from the weboffice provides general information on SPIN activities
- In the events tab you will find a list of national and international events such as conferences, meetings, World Psoriasis Day...
- The news from medical groups showcasing the works shared by the national groups
- The news from patient associations presenting the latest activities of our partner associations
- The recent publications on psoriasis lists the latest Pumed articles on psoriasis and atopic dermatitis
When you wish to share information with the SPIN community, please send it in English to our weboffice. We will then post your news in the news section.
>> Running Projects
In this section you will find all the relevant information about SPIN’s ongoing projects and activities.
>> The Country Sites section
This section fosters the websites of national medical groups and of patient associations. Also, it allows those groups or associations that don’t have a website of their own, to create one for free. To proceed to the creation of your own website, please visit the "Country Sites" section and follow the instructions.
The national websites give you general information about the countries which are part of the network and it aims at:
- Fostering connections in each country between dermatologists and patients,
- Making easier to share information and to engage collaborations between countries.
To design and manage your own website, please use the website management tool.
>> The Website Management Tool
The website management tool is designed for your national medical group or for your patient association. This tool will guide you to build a website in your national language or to create a link with your pre-existent website. To use this section, you need to register. Please go to the website management tool at the bottom right of the homepage.
If you have any question, please, do no hesitate to contact our weboffice.
>> The International Links section
This section provides you links to other international psoriasis and atopic dermatitis organisations.
>> The Keywords section
This section gives you general information about psoriasis. It is a glossary with direct links to Pubmed’s main publications on psoriasis. A similar glossary for atopic dermatitis is to be developed soon.
SPIN Presentation
Recent news
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
- 2019/04/18 Focus on...
- 2019/04/17 Focus on...
- 2018/07/16 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Aliment. Pharmacol. Ther..
2019 Aug , 50, (3):289-294.
Anti-TNFα agents have revolutionised management of chronic inflammatory diseases. Paradoxically, these agents might provoke development of de novo autoimmune diseases.
see on pubmed
Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytes.
Biochem. Biophys. Res. Commun..
2019 Aug 06, 515, (4):665-671.
Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation. Ginsenoside compound K (CK), a bioactive metabolite of ginseng, modulates various skin disorders with an impact on keratinocyte biology. However, the effect of Ginsenoside CK in psoriasis has not been explored.
see on pubmed
A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (TNF-α inhibitor) therapy.
J. Theor. Biol..
2019 Aug 07, 474:63-77.
Psoriasis is a chronic skin condition that produces plaques of condensed, scaling skin due to excessively rapid proliferation of keratinocytes. During the disease progression, keratinocyte proliferation is influenced by many immune cells and cytokines. This article deals with a five dimensional deterministic model, which has been derived using quasi-steady-state approximation for describing the dynamics of psoriasis in various cytokines environment. Equilibrium analysis of the system shows (...)
see on pubmed
on Atopic Dermatitis
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
Campbell M et al.
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
J Ethnopharmacol.
2019 Sep 15, 241:111955.
Rhamnus prinoides (gesho) is an evergreen shrub from East Africa traditionally used for the treatment of illnesses including atopic dermatitis, ear, nose and throat infections, pneumonia, arthritis, brucellosis, flu, indigestion and fatigue.
see on pubmed
Gardenia jasminoides extract without crocin improved atopic dermatitis-like skin lesions via suppression of Th2-related cytokines in Dfe-induced NC/Nga mice.
J Ethnopharmacol.
2019 Sep 15, 241:112015.
Atopic dermatitis (AD) is a pruritic, chronic, relapsing inflammatory skin disease. Gardenia jasminoides extract (GJE) has been used as a traditional remedy for the treatment of various inflammatory diseases, including AD. The specific effects of the extract components, which include crocin, geniposidic acid, and gardenoside, on inflammatory responses in AD are not entirely (...)
see on pubmed
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
Choi EJ et al.
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
J Enzyme Inhib Med Chem.
2019 Dec , 34, (1):613-619.
This study aimed to evaluate the effects of cinnamamides on atopic dermatitis (AD) and the mechanisms underlying these effects. To this end, the actions of two cinnamamides, (E)-3-(4-hydroxyphenyl)-N-phenylethyl acrylamide (NCT) and N-trans-coumaroyltyramine (NCPA), were determined on AD by orally administering them to mice. Oral administration of the cinnamamides ameliorated the increase in epidermal and dermal thickness as well as mast cell infiltration. Cinnamamides suppressed serum (...)
see on pubmed
